(Q44934822)

7 December 2017

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment (English)

1 reference

anaplastic thyroid carcinoma

7 December 2017

0 references

1 reference

1 reference

3

1 reference

7 December 2017

5

David Sidransky

1 reference

7 December 2017

4

Yoram Cohen

1 reference

7 December 2017

6

William H Westra

1 reference

7 December 2017

Shahnaz Begum

1

1 reference

PubMed ID

15195111

7 December 2017

Eli Rosenbaum

series ordinal

2

1 reference

7 December 2017

1 November 2004

1 reference

7 December 2017

1 reference

7 December 2017

17

1 reference

7 December 2017

1359-1363

1 reference

7 December 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800198

7 December 2017

0 references

cites work

Genome-wide appraisal of thyroid cancer progression.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Anaplastic thyroid tumors. Immunohistology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Silencing of thePTENtumor-suppressor gene in anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

The Raf/MEK/ERK pathway: new concepts of activation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Loss of genes on the short arm of chromosome 11 in bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

BRAF as a potential therapeutic target in melanoma and other malignancies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800198

7 January 2021

10.1038/MODPATHOL.3800198

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

15195111